Abstract
Get full access to this article
View all access options for this article.
References
1.
Burack
R
(1975 ) New Handbook of Prescription Drugs . Random House , New York ; p xxiii .
2.
Fattorusso
V
(1981 ) World Health , May, p 3 .
3.
Kewitz
H
(1976 ) Clinical Pharmacological Evaluation in Drug Control: Reports on Symposium . WHO Regional Office for Europe , Copenhagen ; p 56 .
4.
Laurence
D R
(1977 ) Clinical Pharamacology . Churchill Livingstone , Edinburgh ; pp 22.2 –22.6 .
5.
Moertel
C G
Ahmann
D L
Taylor
W F
(1972 ) New England Journal of Medicine
268 , 813 –815 .
6.
O'Brien
P
(1977 ) ISS Occasional Papers No. 63, April.
7.
Rabin
D
Bush
P
(1974 ) International Journal of Health Services
4 , 81 .
8.
Sekhar
C
Raina
R K
Pillai
G K
(1981 ) Tropical Doctor
11 , 116 –118 .
9.
Silverman
M
(1976 ) Competitive Problems in the Drug Industry . Part 32, p 15367 .
10.World Health Organization (1977 ) WHO Technical Report Series
615 .
11.
Yudkin
J
(1977 ) To Plan is to Choose . University of Dar-es-Salaam ; p 9 (mimeographed).